Rx Africa (Ethiopia) PLC Research and Development

List of Generic Pharmaceutical Products in Development

Our new R & D center is fully operational. It is equipped with modern technologies and staffed by high level scientists, including a scientist from West Germany. The following new products have already been formulated:

1. Sulfamethoxazole + Trimetorpim (400+80)mg tablet
2. Methyldopa 250mg tablet
3. Clarithromycin 250mg tablet
4. Ibuprofen 400mg tablet
5. Tetracycline 250mg capsule
6. Metronidazole 250mg capsule
7. Metformin 500mg tablet
8. Albendazole 200mg tablet
9. Sparfloxacillin 500mg tablet

Presently an additional 22 generic pharmaceuticals are under formulation. Therefore we anticipate that by the end of the third quarter of 2009 Rx Africa (Ethiopia) will be in the market with as many as 37 products:

1. Diclofenac sodium 50mg (e/c) tablet
2. Mebendazole 100mg tablet
3. Magnesium with Aluminum Hydroxide compound (250+120mg) tablet
4. Indometacin 25mg capsule
5. Soluble Aspirin 100mg tablets
6. Hyocine Batyl bromide 10mg tablets
7. Vitamin B Complex
8. Sildenafil Citrate 50mg, 100mg tablet
9. Nifedipine 20mg (retard) tablet
10. Ketoconazole 200mg tablet
11. Fluconazole 200mg tablet
12. Prazequantel 600mg tablet (Scored to three piles)
13. Niclosamide 500mg tablet
14. Grseofulvin 125mg tablet
15. Grseofulvin 250mg tablet
16. Sparfloxacillin 500mg tablet
17. Azithromycin 500mg tablet
18. Lisonopril 5, 10mg tablet
19. Amilodipine 5,10mg tablet
20. Ivermectine 3,6mg tablet
21. Thioridazine hydrochloride 100mg of 100x10 tablet
22. Amitriptyllin 25mg of 25x10 tablets

During the 3rd quarter of 2009, we are planning to formulate several HIV and malaria drugs:

HIV
1) Efavirenz
2) Lamivudine
3) Nelfinavir
4) Nevirapine
5) Ritonavir
6) Zidovudine
7) Didanosine
8) Retinovire

Malaria
1) Dihydroartemisinin
2) Mesloqiun
3) Coarten